Jean-Luc Olivier
Overview
Explore the profile of Jean-Luc Olivier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Florent-Bechard S, Malaplate-Armand C, Koziel V, Kriem B, Olivier J, Pillot T, et al.
J Neurol Sci
. 2007 Aug;
262(1-2):27-36.
PMID: 17681547
Alzheimer's disease (AD) is a major public health concern in all countries. Although the precise cause of AD is still unknown, a growing body of evidence supports the notion that...
12.
Youssef I, Florent-Bechard S, Malaplate-Armand C, Koziel V, Bihain B, Olivier J, et al.
Neurobiol Aging
. 2007 Apr;
29(9):1319-33.
PMID: 17459527
N-terminal-truncated forms of amyloid-beta (A beta) peptide have been recently suggested to play a pivotal role early in Alzheimer's disease (AD). Among them, A beta 3(pE)-42 peptide, starting with pyroglutamyl...
13.
Malaplate-Armand C, Florent-Bechard S, Youssef I, Koziel V, Sponne I, Kriem B, et al.
Neurobiol Dis
. 2006 Apr;
23(1):178-89.
PMID: 16626961
Recent data have revealed that soluble oligomeric amyloid-beta peptide (Abeta) may be the proximate effectors of neuronal injuries and death in Alzheimer's disease (AD) by unknown mechanisms. Consistently, we recently...
14.
Florent S, Malaplate-Armand C, Youssef I, Kriem B, Koziel V, Escanye M, et al.
J Neurochem
. 2005 Nov;
96(2):385-95.
PMID: 16300635
A growing body of evidence supports the notion that soluble oligomers of amyloid-beta (Abeta) peptide interact with the neuronal plasma membrane, leading to cell injury and inducing death-signalling pathways that...
15.
Fifre A, Sponne I, Koziel V, Kriem B, Yen Potin F, Bihain B, et al.
J Biol Chem
. 2005 Oct;
281(1):229-40.
PMID: 16234245
A growing body of evidence supports the notion that soluble oligomeric forms of the amyloid beta-peptide (Abeta) may be the proximate effectors of neuronal injuries and death in the early...
16.
Kriem B, Sponne I, Fifre A, Malaplate-Armand C, Lozach-Pillot K, Koziel V, et al.
FASEB J
. 2004 Oct;
19(1):85-7.
PMID: 15486059
Recent data have revealed that soluble oligomeric forms of amyloid peptide (Abeta) may be the proximate effectors of the neuronal injury and death occurring in Alzheimer's disease (AD). However, the...
17.
Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Olivier J, et al.
Glia
. 2004 May;
47(1):1-8.
PMID: 15139007
Neurodegenerative prion diseases, characterized by a progressive dementia, are associated with the accumulation of abnormal forms of the prion (PrPc) protein, potentially due to an aberrant regulation of PrPc biogenesis...
18.
Sponne I, Fifre A, Koziel V, Oster T, Olivier J, Pillot T
FASEB J
. 2004 Mar;
18(7):836-8.
PMID: 15001562
Neuronal cell death in Alzheimer's disease (AD) is partly induced by the interaction of the amyloid-beta peptide (Abeta) with the plasma membrane of target cells. Accordingly, recent studies have suggested...
19.
Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-Raymond M, et al.
J Biol Chem
. 2002 Nov;
278(5):3437-45.
PMID: 12435748
In the present study, we have determined the nature and the kinetics of the cellular events triggered by the exposure of cells to non-fibrillar amyloid-beta peptide (A beta). When cortical...
20.
Meynier de Salinelles V, Berenbaum F, Jacques C, Salvat C, Olivier J, Bereziat G, et al.
FEBS Lett
. 2002 May;
518(1-3):67-71.
PMID: 11997019
We have designed a chimeric promoter that can be stimulated by various pro-inflammatory mediators and so drive the expression of therapeutic genes under inflammatory conditions. The promoter has two parts,...